INSULIN LISPRO

Course overview

INSULIN LISPRO IS AN INSULIN ANALOG THAT IS FDA-APPROVED FOR THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS TYPES 1 AND 2 TO CONTROL HYPERGLYCEMIA. ITS OFF-LABEL USES INCLUDE TREATING PATIENTS WITH MILD-TO-MODERATE DIABETIC KETOACIDOSIS, GESTATIONAL DIABETES MELLITUS, AND MILD-TO-MODERATE HYPEROSMOLAR HYPERGLYCEMIC STATE. ONE UNIT OF INSULIN LISPRO IS AS POTENT AS ONE UNIT OF HUMAN INSULIN IN LOWERING GLUCOSE. THIS ACTIVITY DESCRIBES THE MODE OF ACTION OF INHALED CORTICOSTEROIDS, INCLUDING MECHANISM OF ACTION, PHARMACOLOGY, ADVERSE EVENT PROFILES, ELIGIBLE PATIENT POPULATIONS, MONITORING, AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF CONDITIONS WHERE A RAPID-ACTING INSULIN IS BENEFICIAL FOR PATIENT OUTCOMES IN DIABETES CARE.